AWM
ATRS

Apollon Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Apollon Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,256
Closed -$50K – 820
2022
Q1 		$50K Buy
12,256
+46
+0.4% +$167 ﹤0.01% 737
2021
Q4 		$44K Buy
+12,210
New +$42.7K ﹤0.01% 747

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Apollon Wealth Management's ATRS Position: Q2 2022 in Review

Apollon Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 12,256 shares — an estimated $50K sold.

Apollon Wealth Management first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $50K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Apollon Wealth Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Apollon Wealth Management sold 12,256 Antares Pharma, Inc. shares in Q2 2022, an estimated $50K.
  • Apollon Wealth Management first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
  • Apollon Wealth Management's Antares Pharma, Inc. position peaked at $50K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Apollon Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.